CorMedix Inc. (CRMD) financial statements (2021 and earlier)

Company profile

Business Address 300 CONNELL DRIVE
BERKELEY HEIGHTS, NJ 07922
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4628181220354
Cash and cash equivalents421618108124
Short-term investments412 21224 
Restricted cash and investments0      
Receivables  00000
Inventory, net of allowances, customer advances and progress billings0001000
Inventory0001000
Prepaid expense000010 
Deposits current assets0      
Other undisclosed current assets1111110
Total current assets:4829191322375
Noncurrent Assets
Operating lease, right-of-use asset1 
Property, plant and equipment0000000
Deposits noncurrent assets    000
Total noncurrent assets:1000000
TOTAL ASSETS:4929191322375
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4686431
Accounts payable1132221
Accrued liabilities3554211
Employee-related liabilities      0
Deferred revenue 0
Other undisclosed current liabilities0 0000(0)
Total current liabilities:4686431
Noncurrent Liabilities
Long-term debt and lease obligation106    
Long-term debt, excluding current maturities  6    
Operating lease, liability10
Liabilities, other than long-term debt     00
Deferred revenue and credits  00
Other undisclosed noncurrent liabilities(1)      
Total noncurrent liabilities:106  00
Total liabilities:56146431
Stockholders' equity
Stockholders' equity attributable to parent, including:44245718344
Preferred stock0000000
Common stock0000000
Common stock, value, subscriptions 15     
Additional paid in capital262018415913712880
Deferred compensation equity     (0)(0)
Accumulated other comprehensive income0000000
Accumulated deficit(217)(195)(179)(152)(119)(94) 
Warrants and rights outstanding      12
Other undisclosed stockholders' equity attributable to parent 204    (88)
Total stockholders' equity:44245718344
TOTAL LIABILITIES AND EQUITY:4929191322375

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues0000000
Cost of revenue(0)(0)(0)(0)   
Other undisclosed gross profit    (0)(0)(0)
Gross profit:0(0)00(0)(0)(0)
Operating expenses(27)(21)(27)(33)(25)(17)(9)
Other operating expense, net
(Other Expenses)
 (0)     
Other undisclosed operating income 0     
Operating loss:(27)(21)(27)(33)(25)(17)(9)
Nonoperating income (expense)000000(0)
Investment income, nonoperating 0 0000
Foreign currency transaction loss, before tax (0) (0)(0)(0)(0)
Other nonoperating income0 0    
Interest and debt expense(0)(1)(0)(0)(0)(0)(0)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes0(0)0(0)(0)(2)(11)
Loss from continuing operations before equity method investments, income taxes:(27)(21)(27)(33)(25)(18)(20)
Other undisclosed income from continuing operations before income taxes 0     
Loss from continuing operations before income taxes:(27)(21)(27)(33)(25)(18)(20)
Income tax benefit55     
Net loss:(22)(16)(27)(33)(25)(18)(20)
Other undisclosed net income attributable to parent   0   
Net loss attributable to parent:(22)(16)(27)(33)(25)(18)(20)
Preferred stock dividends and other adjustments     00
Other undisclosed net loss available to common stockholders, basic (27)   (0)(0)
Net loss available to common stockholders, diluted:(22)(44)(27)(33)(25)(18)(21)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(22)(16)(27)(33)(25)(18)(20)
Other comprehensive income (loss)00(0) 0(0)0
Comprehensive loss:(22)(16)(27)(33)(25)(18)(20)
Other undisclosed comprehensive income, net of tax, attributable to parent   0   
Comprehensive loss, net of tax, attributable to parent:(22)(16)(27)(33)(25)(18)(20)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: